Perceive Biotherapeutics, Inc.
Long-Term Follow Up Extension for participants previously enrolled in a VOY-101 study for Advanced Non-Neovascular Age-Related Macular Degeneration
This is a long-term observational, non-interventional extension study to the Phase 1/2a studies that administered VOY-101 to subjects with advanced non-neovascular age-related macular degeneration (AMD).
Inclusion Criteria: 1. Have received an injection of VOY-101 and exited either the PBI-AMD-001 or PBI-AMD-002 Phase 1/2a study of VOY-101. 2. Are willing and able to understand and provide informed consent. Exclusion Criteria: There are no exclusion criteria for this study
No intervention - observational study
One-time intravitreal injection of VOY-101.
Verify or correct the compensation shown for this listing.